Basilea Pharmaceutica Ltd.

Swiss Biotech Association

Member

Basilea Pharmaceutica Ltd. (SIX: BSLN) is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea is committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

https://www.basilea.com
+41 61 606 11 11
info@basilea.com
Dr. Peer Nils Schröder

Location

Hegenheimermattweg 167b, 4123 Allschwil, Switzerland

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

2000
Number of employees in Switzerland

150-249

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

CELLnTEC Advanced Cell Systems

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.
3014 Bern

Member

Caland SA

Caland SA provides a professional, confidential, competitive and impeccable service of pharma-grade CO2 extraction, distillation and cannabis formulation based on GMP requirements.
A modern production line, coupled to a qualified ERP, ensures uncompromising quality of all products and services.
2800 Delémont

Member

Curare Swiss AG

Curare provides strategic advice to assist in the successful design of R&D programs. From the non-clinical to clinical Proof-of-Concept. The right decisions at the right time. Curare's experts put their years of experience and knowledge relating to translational and clinical drug development to use.
4056 Basel

Member